Rumours emanating from Ovetii claim that the firm is poised to invest in one of India’s top pharmaceutical corporations.
United States of America (Press Release) October 29, 2007 --
Although still to be confirmed, rumours coming from a source at Ovetii are that its Private Equity tranche is to commit approximately €20 million to an undisclosed Indian company.
Speculators believe that the company has its foundation in the pharmaceutical industry.
Fuelling the rumours is the recent news of India’s second largest drug-maker’s agreement to take control of Zenotech Laboratories Ltd. which has gained them access to $65 billion market for biotechnology treatments.
If the rumours prove to be correct, this investment could prove to be hugely beneficial for Ovetii and its investors.
So far Ovetii has declined to comment on the rumoured deal.
Speculators believe that the company has its foundation in the pharmaceutical industry.
Fuelling the rumours is the recent news of India’s second largest drug-maker’s agreement to take control of Zenotech Laboratories Ltd. which has gained them access to $65 billion market for biotechnology treatments.
If the rumours prove to be correct, this investment could prove to be hugely beneficial for Ovetii and its investors.
So far Ovetii has declined to comment on the rumoured deal.
Email
Print
SPAM
